Malignant Brain Tumors In Children Will Soon Be Able To Be Curable

Malignant Brain Tumors In Children Will Soon Be Able To Be Curable.
A preparation office has found that a targeted treatment for medulloblastoma - the most worn out malignant brain cancer in children - may one day be able to treat drug-resistant forms of the disease. "Less than 5 percent of patients currently live medulloblastoma," said Dr Amar Gajjar, supremacy author of the study, which was presented Saturday at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. "Most patients customarily die 12 to 18 months after the tumor comes back".

Although this look was designed primarily to assess philosophy effects, if the drug moves through the pharmaceutical pipeline, it would be the first targeted drug aimed at a signaling pathway. Chemotherapy is the mains treatment now. The drug, known as GDC-0449, interrupts the "sonic hedgehog" pathway, which has been implicated in a slew of other cancers; it is involved in 20 percent of cases of children with medulloblastoma.